HMB (β-hydroxy β-methylbutyrate)
Sleep & Recovery · Leucine metabolite
Tier B+
Bottom line
Read Off Label grades HMB (β-hydroxy β-methylbutyrate) as B+ (7.2/10) based on moderate evidence, low-med benefit magnitude, and a very low-risk safety profile.
Benefit signals are concentrated in studies of age-related sarcopenia, bed rest, and training novices; effects in trained lifters seeking additional gains are smaller or inconsistent.
Studied, labeled, or reported-use context: 3 g/day PO divided (commonly 1 g 3x/day); calcium HMB or free-acid HMB — OTC; not individualized guidance.
What the evidence says
Benefit signals are concentrated in studies of age-related sarcopenia, bed rest, and training novices; effects in trained lifters seeking additional gains are smaller or inconsistent. Wilson 2013 ISSN position stand is the standard reference. Free-acid form better absorbed than calcium HMB.
Mechanism
Downstream metabolite of leucine (~5% of leucine converts to HMB); upregulates mTORC1, downregulates proteasomal/autophagic protein breakdown; anti-catabolic more than anabolic
Studied, labeled, or reported dose & route
3 g/day PO divided (commonly 1 g 3x/day); calcium HMB or free-acid HMB
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
- PubMed · PMID 23374455
- PubMed · PMID 23924954
- pmc.ncbi.nlm.nih.gov
- DOI · 10.1177/21621918261444178
- DOI · 10.1097/mcc.0000000000001386
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about HMB (β-hydroxy β-methylbutyrate)'s effects?
- Read Off Label rates the evidence for HMB (β-hydroxy β-methylbutyrate) as Moderate and the benefit magnitude as low-med, producing an overall grade of B+ (7.2/10). Benefit signals are concentrated in studies of age-related sarcopenia, bed rest, and training novices; effects in trained lifters seeking additional gains are smaller or inconsistent.
- What safety findings are reported for HMB (β-hydroxy β-methylbutyrate)?
- HMB (β-hydroxy β-methylbutyrate) has a very low risk profile in the database. Very Low Legal status: OTC.
- What doses or routes are reported for HMB (β-hydroxy β-methylbutyrate)?
- 3 g/day PO divided (commonly 1 g 3x/day); calcium HMB or free-acid HMB This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does HMB (β-hydroxy β-methylbutyrate) work?
- Downstream metabolite of leucine (~5% of leucine converts to HMB); upregulates mTORC1, downregulates proteasomal/autophagic protein breakdown; anti-catabolic more than anabolic
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.